Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
Help Your Efficiency with These Work area Updates- Figure out How to Explore the Infotainment Framework in the Slam 1500.
- Is an $85 apple pie worth it? Our Thanksgiving taste test says … maybe.
- Jenny & Dave Marrs Mourn Loss of Former ‘Fixer to Fabulous: Italiano’ Guest
- First SpaceX booster for upgraded Starship fails during test in Texas
- A definitive Manual for Choosing Indoor Plants Ideal for Your Space
- Instructions to Grasp the Innovation Behind 5G Pinnacles\
- Exploring the Difficulties of Beginning a Family: Individual Experiences
- REWE launches seventh Pick&Go test store in Hanover
